지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.3
- 수록면
- 21 - 26 (6page)
이용수
초록· 키워드
오류제보하기
The present study describes the development of DNA vaccines using the hemagglutinin-neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression analysis of the constructs in Vero cells revealed the successful expression of gene inserts in vitro. Moreover, in vivo experiments showed that single vaccination with the constructed plasmid DNA (pDNA) followed by a boost with inactivated vaccine induced a significant difference in enzyme-linked immunosorbent assay antibody levels (p < 0.05) elicited by either pIRES/F, pIRES/F+ pIRES/HN or pIRES-F/HN at one week after the booster in specific pathogen free chickens when compared with the inactivated vaccine alone. Taken together, these results indicated that recombinant pDNA could be used to increase the efficacy of the inactivated vaccine immunization procedure.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine
Clinical and Experimental Vaccine Research
2021 .09
-
Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain
Clinical and Experimental Vaccine Research
2021 .01
-
Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs
Clinical and Experimental Vaccine Research
2020 .01
-
The Characteristics of RNA Vaccine
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2016 .09
-
Recombinant-attenuated Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Pullorum challenge
Journal of Veterinary Science
2018 .03
-
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development
Clinical and Experimental Vaccine Research
2024 .04
-
A novel M2e-multiple antigenic peptide providing heterologous protection in mice
Journal of Veterinary Science
2016 .03
-
Recent vaccine technology in industrial animals
Clinical and Experimental Vaccine Research
2016 .01
-
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Annals of geriatric medicine and research
2021 .01
-
Advancements in Cancer Immunotherapy: The Evolution and Future of mRNA and DNA Vaccine Technologies
대한의생명과학회지
2025 .03
-
Exploring the experience of developing COVID-19 vaccines in Iran
Clinical and Experimental Vaccine Research
2023 .01
-
Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease
지질·동맥경화학회지
2024 .09
-
Establishment of the 1st National Reference Standard for Sabin Inactivated Poliomyelitis Vaccine in Korea
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2021 .12
-
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
Journal of Korean Medical Science
2021 .01
-
Should the COVID-19 Vaccine be Administered Simultaneously with Other Vaccines?
Infection and Chemotherapy
2021 .09
-
Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges
Clinical and Experimental Vaccine Research
2020 .01
-
Parenteral, non-live rotavirus vaccine: recent history and future perspective
Clinical and Experimental Vaccine Research
2021 .09
-
Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines
Immune Network
2015 .10
-
Who Influences the Public Intention to Get a COVID-19 Vaccine and What are the Public References and Concerns? A Population Survey in Vietnam
Infection and Chemotherapy
2021 .12
-
Current development of therapeutic vaccines for the treatment of chronic infectious diseases
Clinical and Experimental Vaccine Research
2024 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-528-001364893